Middle East & Africa Gastrointestinal Drugs Market to Grow at a CAGR of 3.3% to reach US$ 2,573.94 million from 2020 to 2027
Pharmaceuticals Middle East & Africa Gastrointestin...

Middle East & Africa Gastrointestinal Drugs Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Drug Class (Acid Neutralizers, Antidiarrheal and Laxatives, Anti-Inflammatory Drugs, Antiemetic and Antinauseants, Biologics, and Others); Route of Administration (Oral, and Parenteral); Application (Inflammatory Ulcerative Colitis, Crohn's Disease, Irritable Bowel Syndrome, Gastroenteritis, Celiac Disease, and Others); and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Country

Publication Month: Nov 2020 | Report Code: TIPRE00016306 | No. of Pages: 140 | Category: Pharmaceuticals | Status: Published
Covid

The Middle East & Africa gastrointestinal drugs market is expected to reach US$ 2,573.94 million by 2027 from US$ 2,000.27 million in 2019; it is estimated to grow at a CAGR of 3.3 % from 2020 to 2027.

Rising prevalence of gastrointestinal (GI) diseases, and increase in development of biologics are the key factors driving the growth of gastrointestinal drugs. However, side effects associated with the drugs is the major factor hindering the market growth in Asia Pacific.

 

Gastrointestinal (GI) disorders are the medical conditions related to the digestive system that affect the colon, small and large intestine, and rectum. The disorders include constipation, irritable bowel, ulcerative colitis, and peptic ulcer diseases. These disorders are characterized by various symptoms such as pain, bloating, diarrhoea, nausea, and vomiting. These disorders constitute a large proportion of outpatients and frequent hospital visits. A wide range of GI drugs is commercially available in the market for the treatment of various conditions. Additionally, rising investments in the development of biologics and the emergence of a biosimilar are expected to drive the growth of the Middle East & Africa Gastrointestinal Drugs market in the forecast period.

Gastrointestinal diseases are becoming prevalent. Rapidly progressing research activities in drug development of novel therapeutics are driving the growth of the market. Many research institutes are offering funding to accelerate the discovery of novel methods for the treatment of GI disorders, which is offering lucrative opportunities for the discovery of new therapies. The major research areas are understanding mechanisms responsible for pancreatic inflammation and pancreatitis genetics and immunobiology of inflammatory bowel disease.

Moreover, the pharmaceutical industry is continually evolving. There is always a need for new, innovative therapeutic approaches in the treatment of various GI indications. The GI candidates-based pipeline is growing for a wide range of therapeutic applications, including Crohn's disease, Ulcerative colitis, inflammatory bowel disease, and others. Many big and small pharmaceutical companies are engaged in the development of several GI biologics drugs. Thus, the growing innovative pipeline of GI drugs is, in turn, boosting the drug discovery activities across the industry.

 

Middle East countries have registered a growth in the number of COVID cases in the last few days, with the UAE registering 85,595 cases, Saudi Arabia reporting 336,766, and South Africa indicating 682,215 confirmed cases. However, gastrointestinal drug market in this pandemic is on rising, due to the increasing awareness about treatments of gastrointestinal disorders in the region.

                                                                          

Rest of Middle East & Africa Gastrointestinal drugs Market, Revenue and Forecast to 2027 (US$ Mn)

Rest of Middle East & Africa Gastrointestinal drugs Market, Revenue and Forecast to 2027 (US$ Mn)

Get more information on this report :


         

MIDDLE EAST & AFRICA GASTROINTESTINAL DRUGS MARKET SEGMENTATION

 

By Drug Class

  • Acid Neutralizers
  • Antidiarrheal and Laxatives
  • Anti-Inflammatory Drugs
  • Antiemetic and Antinauseants
  • Biologics
  • Others

 

By Route of Administration

  • Oral
  • Parenteral

 

By Application

  • Inflammatory Ulcerative Colitis
  • Crohn's Disease
  • Irritable Bowel Syndrome
  • Gastroenteritis
  • Celiac Disease
  • Others

 

By Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

 

By Country

  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East and Africa

 

Company Profiles

  • Johnson and Johnson Services, Inc.
  • GlaxoSmithKline plc
  • Celltrion Healthcare Co.,Ltd.
  • AstraZeneca
  • Takeda Pharmaceutical Company Limited

 

1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        Middle East and Africa Gastrointestinal Drugs Market – By Drug Class

1.3.2        Middle East and Africa Gastrointestinal Drugs Market – By Route of Administration

1.3.3        Middle East and Africa Gastrointestinal Drugs Market – By Application

1.3.4        Middle East and Africa Gastrointestinal drugs Market – By Distribution Channel

1.3.5        Middle East and Africa Gastrointestinal drugs Market – By Country

2.          Middle East and Africa Gastrointestinal Drugs Market  Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          Middle East and Africa Gastrointestinal Drugs Market  Market Landscape

4.1        Overview

4.2        PEST Analysis

4.2.1        Gastrointestinal Drugs Market - Middle East and Africa PEST Analysis

4.3        Expert Opinion

5.          Middle East and Africa Gastrointestinal Drugs Market  Key Market Dynamics

5.1        Key Market Drivers

5.1.1        Rise in Prevalence of Gastrointestinal (GI) Diseases

5.1.2        Increase in Development of Biologics

5.2        Market Restraints

5.2.1        Low Awareness Associated with Gastrointestinal Disorders in Low-Income Economies

5.3        Market Opportunities

5.3.1        Increasing Investment in Research Activities and Growing Pipeline of GI Candidates

5.4        Future Trends

5.4.1        Emergence of Biosimilars

5.5        Impact Analysis

6.          Gastrointestinal Drugs Market – Middle East and Africa Analysis

6.1        Middle East and Africa Gastrointestinal Drugs Market Revenue Forecasts and Analysis

7.          Middle East and Africa Gastrointestinal Drugs Market Analysis And Forecasts To 2027 – By Drug Class

7.1        Overview

7.2        Middle East and Africa Gastrointestinal Drugs Market, By Drug Class 2019 & 2027 (%)

7.2.1        Middle East and Africa Gastrointestinal drugs Market Revenue and Forecasts to 2027, By Drug Class (US$ Mn)

7.3        Acid Neutralizers

7.3.1        Overview

7.3.2        Middle East and Africa Acid Neutralizers Market Revenue and Forecast to 2027 (US$ Mn)

7.4        Antidiarrheal and Laxatives

7.4.1        Overview

7.4.2        Middle East and Africa Antidiarrheal and Laxatives Market Revenue and Forecasts to 2027 (US$ Mn)

7.5        Anti-Inflammatory Drugs

7.5.1        Overview

7.5.2        Middle East and Africa Anti-Inflammatory Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

7.6        Antiemetic and Antinauseants

7.6.1        Overview

7.6.2        Middle East and Africa Antiemetic and Antinauseants Market Revenue and Forecast to 2027 (US$ Mn)

7.7        Biologics

7.7.1        Overview

7.7.2        Middle East and Africa Biologics Market Revenue and Forecasts to 2027 (US$ Mn)

7.8        Others

7.8.1        Overview

7.8.2        Middle East and Africa Others Market Revenue and Forecasts to 2027 (US$ Mn)

8.          Middle East and Africa Gastrointestinal Drugs Market Analysis – By Route of Administration

8.1        Overview

8.2        Middle East and Africa Gastrointestinal Drugs Market, By Route of Administration 2019-2027 (%)

8.2.1        Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts to 2027, By Route of Administration (US$ Mn)

8.3        Oral

8.3.1        Overview

8.3.2        Middle East and Africa Oral Market Revenue and Forecasts to 2027 (US$ Mn)

8.4        Parenteral

8.4.1        Overview

8.4.2        Middle East and Africa Parenteral Market Revenue and Forecasts to 2027 (US$ Mn)

9.          Middle East and Africa Gastrointestinal Drugs Market Analysis – By Application

9.1        Overview

9.2        Middle East and Africa Gastrointestinal Drugs Market, By Application 2019-2027 (%)

9.2.1        Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts to 2027, By Application (US$ Mn)

9.3        Inflammatory Ulcerative Colitis

9.3.1        Overview

9.3.2        Middle East and Africa Inflammatory Ulcerative Colitis Market Revenue and Forecasts to 2027 (US$ Mn)

9.4        Crohn's Disease

9.4.1        Overview

9.4.2        Middle East and Africa Crohn's Disease Market Revenue and Forecasts to 2027 (US$ Mn)

9.5        Irritable Bowel Syndrome

9.5.1        Overview

9.5.2        Middle East and Africa Irritable Bowel Syndrome Market Revenue and Forecasts to 2027 (US$ Mn)

9.6        Gastroenteritis

9.6.1        Overview

9.6.2        Middle East and Africa Gastroenteritis Market Revenue and Forecasts to 2027 (US$ Mn)

9.7        Celiac Disease

9.7.1        Overview

9.7.2        Middle East and Africa Celiac Disease Market Revenue and Forecasts to 2027 (US$ Mn)

9.8        Others

9.8.1        Overview

9.8.2        Middle East and Africa Others Market Revenue and Forecasts to 2027 (US$ Mn)

10.       Middle East and Africa Gastrointestinal Drugs Market Analysis – By Distribution Channel

10.1      Overview

10.2      Middle East and Africa Gastrointestinal Drugs Market, By Distribution Channel 2019-2027 (%)

10.2.1     Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)

10.3      Hospital Pharmacies

10.3.1     Overview

10.3.2     Middle East and Africa Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

10.4      Retail Pharmacies

10.4.1     Overview

10.4.2     Middle East and Africa Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

10.5      Online Pharmacies

10.5.1     Overview

10.5.2     Middle East and Africa Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

11.       Gastrointestinal Drugs Market Revenue and Forecasts To 2027 – Geographical Analysis

11.1      Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts To 2027

11.1.1     Overview

11.1.2     Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)

11.1.2.1       Middle East & Africa Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

11.1.2.2       Middle East & Africa Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

11.1.2.3       Middle East & Africa Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.1.2.4       Middle East & Africa Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.1.3     Middle East & Africa: Gastrointestinal Drugs Market, by Country, 2019 & 2027 (%)

11.1.3.1       Saudi Arabia: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.1.3.1.1       Saudi Arabia: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.1.3.2       Saudi Arabia Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

11.1.3.3       Saudi Arabia Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027(USD Million)

11.1.3.4       Saudi Arabia Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.1.3.5       Saudi Arabia Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.1.3.6       UAE: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.1.3.6.1       UAE: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.1.3.7       UAE Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

11.1.3.8       UAE Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

11.1.3.9       UAE Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.1.3.10    UAE Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.2      South Africa Gastrointestinal Drugs Market Revenue and Forecasts to 2025 (US$ Mn)

11.2.1     South Africa Gastrointestinal Drugs Market Revenue and Forecasts To 2027 (US$ Mn)

11.2.1.1       South Africa Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

11.2.1.2       South Africa Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

11.2.1.3       South Africa Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.2.1.4       South Africa Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.3      Rest of Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts to 2025 (US$ Mn)

11.3.1     Rest of Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts To 2027 (US$ Mn)

11.3.1.1       Rest of Middle East and Africa Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

11.3.1.2       Rest of Middle East and Africa Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

11.3.1.3       Rest of Middle East and Africa Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.3.1.4       Rest of Middle East and Africa Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

12.       Impact of COVID-19 Pandemic on Middle East and Africa Gastrointestinal Drugs Market

12.1      Middle East and Africa: Impact Assessment of COVID-19 Pandemic

13.       Company Profiles

13.1      Takeda Pharmaceutical Company Limited

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Celltrion Healthcare Co.,Ltd.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      GlaxoSmithKline plc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      AstraZeneca

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Johnson and Johnson Services, Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

14.       Appendix

14.1      Glossary of Terms

LIST OF TABLES

Table 1.            Middle East and Africa Gastrointestinal drugs Market Revenue and Forecasts To 2027, By Drug Class (US$ Mn)

Table 2.            Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts To 2027, By Route of Administration (US$ Mn)

Table 3.            Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 4.            Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 5.            Middle East & Africa Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 6.            Middle East & Africa Gastrointestinal Drugs Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)

Table 7.            Middle East & Africa Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027  (USD Million)

Table 8.            Middle East & Africa Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 9.            Saudi Arabia Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 10.          Saudi Arabia Gastrointestinal Drugs Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)

Table 11.          Saudi Arabia Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 12.          Saudi Arabia Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 13.          UAE Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 14.          UAE Gastrointestinal Drugs Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)

Table 15.          UAE Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 16.          UAE Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 17.          South Africa Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 18.          South Africa Gastrointestinal Drugs Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)

Table 19.          South Africa Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 20.          South Africa Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 21.          Rest of Middle East and Africa Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 22.          Rest of Middle East and Africa Gastrointestinal Drugs Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)

Table 23.          Rest of Middle East and Africa Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 24.          Rest of Middle East and Africa Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 25.          Glossary of Terms, Gastrointestinal Drugs Market

LIST OF FIGURES

Figure 1.           Gastrointestinal Drugs Market Segmentation

Figure 2.           Middle East and Africa Gastrointestinal Drugs Market Overview

Figure 3.           Acid Neutralizers Segment Held Largest Share of Product in Gastrointestinal Drugs Market

Figure 4.           Saudi Arabia is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           Middle East and Africa Gastrointestinal Drugs Market - Leading Country Markets (US$ Mn)

Figure 6.           Gastrointestinal Drugs Market - Middle East and Africa PEST Analysis

Figure 7.           Gastrointestinal Drugs Market Impact Analysis of Drivers and Restraint

Figure 8.           Middle East and Africa Gastrointestinal Drugs market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.           Middle East and Africa Gastrointestinal Drugs Market, By Drug Class 2019 & 2027 (%)

Figure 10.        Middle East and Africa Acid Neutralizers Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11.        Middle East and Africa Antidiarrheal and Laxatives Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.        Middle East and Africa Anti-Inflammatory Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13.        Middle East and Africa Antiemetic and Antinauseants Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14.        Middle East and Africa Biologics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15.        Middle East and Africa Anti-Inflammatory Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16.        Middle East and Africa Gastrointestinal Drugs Market, by Route of Administration 2019 & 2027 (%)

Figure 17.        Middle East and Africa Oral Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.        Middle East and Africa Parenteral Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.        Middle East and Africa Gastrointestinal Drugs Market, by Application 2019 & 2027 (%)

Figure 20.        Middle East and Africa Inflammatory Ulcerative Colitis Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.        Middle East and Africa Crohn's Disease Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22.        Middle East and Africa Irritable Bowel Syndrome Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23.        Middle East and Africa Gastroenteritis Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24.        Middle East and Africa Celiac Disease Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25.        Middle East and Africa Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26.        Middle East and Africa Gastrointestinal Drugs Market, by Distribution Channel 2019 & 2027 (%)

Figure 27.        Middle East and Africa Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 28.        Middle East and Africa Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 29.        Middle East and Africa Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 30.        Middle East & Africa: Gastrointestinal Drugs Market, by Key Country – Revenue (2019) (USD Million)

Figure 31.        Middle East & Africa Gastrointestinal Drugs Market Revenue and Forecast to 2027 (USD Million)

Figure 32.        Middle East & Africa: Gastrointestinal Drugs Market, by Country, 2019 & 2027 (%)

Figure 33.        Saudi Arabia: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 34.        UAE: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 35.        South Africa Gastrointestinal drugs market Revenue and Forecasts to 2027 (US$ Mn)

Figure 36.        Rest of Middle East and Africa Gastrointestinal drugs market Revenue and Forecasts to 2027 (US$ Mn)

Figure 37.        Impact of COVID-19 Pandemic on Gastrointestinal Drugs market in Middle East And Africa

 

  1. Johnson and Johnson Services, Inc.
  2. GlaxoSmithKline plc
  3. Celltrion Healthcare Co.,Ltd.
  4. AstraZeneca
  5. Takeda Pharmaceutical Company Limited
  • It provides understanding of the Middle East & Africa, gastrointestinal drugs market landscape and identifies gastrointestinal drugs market segments that are most likely to guarantee a strong return.
  • It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the Middle East & Africa gastrointestinal drugs market.
  • It helps efficiently plan merger and acquisition, and partnership deals in the gastrointestinal drugs market by identifying market segments with the most promising probable sales
  • It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of gastrointestinal drugs market performance of various segments pertaining to the Middle East & Africa gastrointestinal drugs market.
  • It provides gastrointestinal drugs market revenue forecast of the market based on various segments for the period from 2019 to 2027.
TIPRE00016306
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Contact Us : +1-646-491-9876 | +91-20-67271633 | Email : sales@theinsightpartners.com
© Copyright 2020 - The Insight Partners. All rights reserved